Hemodialysis Access Promise from Polymer Implant

Hemodialysis Access Promise from Polymer Implant

Netherlands and US-based medtech company Xeltis tells us about its first-in-human (FIH) vascular conduit trial for hemodialysis access. Vascular surgeon Prof. Dr. Frans Moll presented the data at the 50thAnnual VEITH symposium in New York. In a subsequent news release the company describes the...

Latest News

Cardiology

Approvals / Clearance

Clinical Studies / Trials